Report post

Who is cabaletta bio?

We are a clinical-stage biotechnology company working to develop and launch potentially breakthrough engineered T cell therapies for patients with autoimmune diseases. Sign up for email alerts to stay informed and receive updates directly to your inbox. © 2024 Cabaletta Bio, Inc. All Rights Reserved.

What does cabaletta bio stand for?

The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio, Inc. (CABA): Why Are Analysts Loving This Shorted Stock Right Now?

Who owns cabaletta Bio Inc?

The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA. CABA | Complete Cabaletta Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

The World's Leading Crypto Trading Platform

Get my welcome gifts